Cipla Limited amends Pulmazole agreement with Pulmatrix
Cipla Limited said that its fully-owned step-down subsidiary — Cipla Technologies (CipTec) has completed an amendment to a previously signed agreement with US-based Pulmatrix for ... Read More
Pulmazole phase 2 clinical study gets FDA approval for Pulmazole in allergic bronchopulmonary aspergillosis
Pulmatrix, the Massachusetts-based biopharmaceutical company, has received approval from the US Food and Drug Administration (FDA) to initiate a phase 2 clinical trial for Pulmazole ... Read More